NVCR - Company ID 0001645113
The table below shows NovoCure Ltd's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $93.55M | $163.77M | $240.82M | $115.33M | $208.80M | $234.67M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $89.44M | $74.23M | $61.22M | $86.26M | $93.57M | $96.70M |
| Inventory | $41.11M | $35.09M | $38.15M | $29.38M | $24.43M | $27.42M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $646.73M |
| $1.11B |
| $1.03B |
| $1.11B |
| $1.07B |
| $999.44M |
| Property, plant & equipment | $77.61M | $77.66M | $51.48M | $32.68M | $22.69M | $11.39M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $804.33M | $1.24B | $1.15B | $1.19B | $1.14B | $1.05B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $223.23M | $756.38M | $179.12M | $158.78M | $142.60M | $113.61M |
| Long-term debt | $195.05M | $97.30M | $568.82M | $565.51M | $562.22M | $429.90M |
| Total liabilities | $463.86M | $880.61M | $783.63M | $750.48M | $729.00M | $575.46M |
| Retained earnings | -$1.29B | -$1.15B | -$985.50M | -$778.46M | -$685.93M | -$631.08M |
| Total equity | $340.47M | $360.18M | $362.50M | $441.17M | $410.49M | $476.53M |